Comment and response
Posted: Mar 4, 2021

Are drug-pricing changes helping or harming Canadians?

An article published on Feb. 2 argues that the PMPRB, a federal regulatory agency, must push ahead with reforms to the pricing of pharmaceutical drugs, despite pressure from Big Pharma.

A critical reply instead argues that the pricing changes will ultimately harm Canadians.

by Danyaal Raza

If the government is serious about ensuring access to prescription drugs and vaccines to all, it must stand up to pressure from Big Pharma on pricing reforms.

VS
by Jason Field

Canadian patients, scientists and health systems are paying the price for this failed policy experiment, which is not what our country needs at this critical moment.

Leave a Comment

Your email address will not be published. Required fields are marked *